FDA Drug Application (075128) for AFEDITAB CR by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number075128
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAFEDITAB CR
Active IngredientNIFEDIPINE

Active IngredientCount
List of drugs with Active Ingredient NIFEDIPINE6


Back to FDA Applications sponsored by WATSON LABS